1. Home
  2. CMPS vs SNFCA Comparison

CMPS vs SNFCA Comparison

Compare CMPS & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • SNFCA
  • Stock Information
  • Founded
  • CMPS 2020
  • SNFCA 1965
  • Country
  • CMPS United Kingdom
  • SNFCA United States
  • Employees
  • CMPS N/A
  • SNFCA N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • SNFCA Finance: Consumer Services
  • Sector
  • CMPS Health Care
  • SNFCA Finance
  • Exchange
  • CMPS Nasdaq
  • SNFCA Nasdaq
  • Market Cap
  • CMPS 301.7M
  • SNFCA 285.8M
  • IPO Year
  • CMPS 2020
  • SNFCA N/A
  • Fundamental
  • Price
  • CMPS $4.49
  • SNFCA $13.30
  • Analyst Decision
  • CMPS Strong Buy
  • SNFCA
  • Analyst Count
  • CMPS 7
  • SNFCA 0
  • Target Price
  • CMPS $30.67
  • SNFCA N/A
  • AVG Volume (30 Days)
  • CMPS 1.1M
  • SNFCA 63.4K
  • Earning Date
  • CMPS 10-31-2024
  • SNFCA 11-14-2024
  • Dividend Yield
  • CMPS N/A
  • SNFCA N/A
  • EPS Growth
  • CMPS N/A
  • SNFCA N/A
  • EPS
  • CMPS N/A
  • SNFCA 1.23
  • Revenue
  • CMPS N/A
  • SNFCA $330,162,091.00
  • Revenue This Year
  • CMPS N/A
  • SNFCA N/A
  • Revenue Next Year
  • CMPS N/A
  • SNFCA N/A
  • P/E Ratio
  • CMPS N/A
  • SNFCA $10.62
  • Revenue Growth
  • CMPS N/A
  • SNFCA N/A
  • 52 Week Low
  • CMPS $4.05
  • SNFCA $6.19
  • 52 Week High
  • CMPS $12.75
  • SNFCA $13.41
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 35.82
  • SNFCA 90.44
  • Support Level
  • CMPS $4.34
  • SNFCA $12.76
  • Resistance Level
  • CMPS $4.66
  • SNFCA $13.41
  • Average True Range (ATR)
  • CMPS 0.34
  • SNFCA 0.55
  • MACD
  • CMPS 0.02
  • SNFCA 0.17
  • Stochastic Oscillator
  • CMPS 8.82
  • SNFCA 96.82

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About SNFCA Security National Financial Corporation

Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.

Share on Social Networks: